Hiroki Miyano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroki Miyano has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Akira Mizutani
Department of Pediatrics and Adolescent Medicine Juntendo University Graduate School of Medicine Tokyo Japan
1 shared publication- Amane Endo
Department of Pediatrics and Adolescent Medicine Juntendo University Graduate School of Medicine Tokyo Japan
1 shared publication - Koji Sakuraya
Division of Nephrology, Saitama Children’s Medical Center, Saitama city, Japan
1 shared publication - Mayu Nakagawa
Department of Pediatrics Juntendo University Faculty of Medicine Tokyo Japan
1 shared publication - Naoto Nishizaki
Department of Pediatrics Juntendo University Urayasu Hospital Chiba Japan
1 shared publication - Shuichiro Fujinaga
Division of Nephrology, Saitama Children’s Medical Center, Saitama, Japan
1 shared publication
Latest Publications
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70000
Inhibition of renal fibrosis via Nrf2 activators for unilateral ureteral obstruction in a rat model
Background: Reactive oxygen species aggravate renal fibrosis, prompting the activation of nuclear factor erythroid 2‐related factor 2 (Nrf2), a key mediator in the cellular response to oxygen stress. Nrf2 exerts renoprotective effects by upregulating antioxidant response element (ARE)‐dependent genes that antagonize renal fibrosis. Elucidating mechanisms to attenuate renal fibrosis in children is essential for developing therapeutic interventions. This study aimed to examine the renoprotective effects of Nrf2 activators on ARE action in rats with unilateral ureteral obstruction (UUO)‐induced renal injury. Methods: The time course of Nrf2 was evaluated in 8‐week‐old male Sprague–Dawley rats with UUO, with or without Nrf2 activators (bardoxolone methyl) for 2 weeks postoperatively. Kidney tissues were collected on Days 7 and 14 post‐surgery. Renoprotective effects were examined using real‐time polymerase chain reaction (RT‐PCR) and histopathological analyses of kidney samples. Results: Nrf2 activators reduced the interstitial fibrotic area in UUO kidneys, causing a substantial decline in ED‐1‐positive cell infiltration and transforming growth factor‐β expression. RT‐PCR revealed that Nrf2 activators suppressed the expression of renal fibrotic factors and promoted the expression of ARE‐dependent genes. Moreover, immunostaining for Nrf2 demonstrated increased nuclear translocation and activation induced by Nrf2 activators. Conclusions: Nrf2 activators induced nuclear translocation and activation of Nrf2, resulting in upregulation of ARE‐dependent genes. Although the function of Nrf2 in children is often unknown, this study may lead to future progress in oxidation and antioxidant function in children.
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70000
Inhibition of renal fibrosis via Nrf2 activators for unilateral ureteral obstruction in a rat model
Background: Reactive oxygen species aggravate renal fibrosis, prompting the activation of nuclear factor erythroid 2‐related factor 2 (Nrf2), a key mediator in the cellular response to oxygen stress. Nrf2 exerts renoprotective effects by upregulating antioxidant response element (ARE)‐dependent genes that antagonize renal fibrosis. Elucidating mechanisms to attenuate renal fibrosis in children is essential for developing therapeutic interventions. This study aimed to examine the renoprotective effects of Nrf2 activators on ARE action in rats with unilateral ureteral obstruction (UUO)‐induced renal injury. Methods: The time course of Nrf2 was evaluated in 8‐week‐old male Sprague–Dawley rats with UUO, with or without Nrf2 activators (bardoxolone methyl) for 2 weeks postoperatively. Kidney tissues were collected on Days 7 and 14 post‐surgery. Renoprotective effects were examined using real‐time polymerase chain reaction (RT‐PCR) and histopathological analyses of kidney samples. Results: Nrf2 activators reduced the interstitial fibrotic area in UUO kidneys, causing a substantial decline in ED‐1‐positive cell infiltration and transforming growth factor‐β expression. RT‐PCR revealed that Nrf2 activators suppressed the expression of renal fibrotic factors and promoted the expression of ARE‐dependent genes. Moreover, immunostaining for Nrf2 demonstrated increased nuclear translocation and activation induced by Nrf2 activators. Conclusions: Nrf2 activators induced nuclear translocation and activation of Nrf2, resulting in upregulation of ARE‐dependent genes. Although the function of Nrf2 in children is often unknown, this study may lead to future progress in oxidation and antioxidant function in children.